CVS Health
Integrated US pharmacy, insurance, care delivery and retail media company.
Die verfügbaren Informationen unterscheiden sich je nach Unternehmen und Quelle.
Profil-Datensatz aktualisiert:
Unternehmensdaten
- Offizieller Name
- CVS Health Corporation
- Einheitentyp
- COMPANY
- Hauptsitz
- United States
- Unternehmensgröße
- >5,000
- Marktrolle
- Other / Non-Digital Advertising Relevant
- Börsenkürzel
- CVS
- Offizielle Website
- cvshealth.com
Was CVS Health macht
CVS Health operates an integrated healthcare model that connects insurance coverage, pharmacy benefit administration, prescription dispensing, clinical care delivery and consumer retail. Aetna contracts with employers, government programmes and members for health coverage. CVS Caremark administers pharmacy benefits for plan sponsors, while CVS Pharmacy, CVS Specialty and mail-order services fulfil prescriptions. Oak Street Health and Signify Health support payer-funded value-based care and in-home evaluations. Cordavis commercialises biosimilars with pharmaceutical manufacturers. CVS Media Exchange monetises CVS-owned shopper touchpoints and first-party loyalty audiences through advertising inventory and campaign services.
Einordnung und Abgrenzung
CVS Health is the parent healthcare corporation, not solely the CVS Pharmacy retail chain or the CVS Media Exchange retail media unit. It is not a pure health insurer, pharmacy benefit manager or retailer because it operates all of these businesses alongside care-delivery assets.
Strategische Einordnung
KI-gestützte Einordnung aus der bestehenden Unternehmensrecherche; Interpretation und belegte Fakten sind zu unterscheiden.
CVS Health Corporation is a publicly listed US health solutions company integrating retail pharmacy, pharmacy benefit management, health insurance, specialty pharmacy, primary care, in-home health assessments and value-based care. Its principal businesses include Aetna, CVS Caremark, CVS Pharmacy, CVS Specialty, MinuteClinic, Oak Street Health, Signify Health and Cordavis. CVS Media Exchange operates a separate retail media network serving brands and agencies using CVS Pharmacy and ExtraCare shopper audiences. The company earns insurance premiums; pharmacy-benefit administration and pharmacy-network economics; prescription, specialty-drug and retail merchandise sales; payer reimbursements and value-based-care payments; pharmaceutical commercialisation revenue; and advertising revenue. Customers include employers, insurers, government health programmes, plan sponsors, pharmaceutical manufacturers, healthcare providers, patients, consumers, consumer-product brands and advertising agencies.
Unternehmens-Newsbriefing
Briefing aktualisiert:
CVS Health verzeichnete starke Ergebnisse für das zweite Quartal 2026 mit einem konsolidierten Umsatzwachstum von 7,3 %, angetrieben durch betriebliche Vereinfachung, KI-Implementierung und den Ausbau von GLP-1-Therapien sowie integrierten Gesundheitsdiensten. Über CVS Health Ventures beteiligt sich das Unternehmen an der 200-Millionen-Dollar-Series-B-Finanzierung von Simile und nutzt Verhaltensmodelle sowie synthetische Populationen für Unternehmenssimulationen. Darüber hinaus fördert der CVS Health Media Exchange durch eine Partnerschaft mit Circana die händlerübergreifende Erfolgsmessung, während das Filialangebot durch GLP-1-freundliche Produktlinien wie Shakes von Kate Farms erweitert wird.
Geschäftsmodell und Monetarisierung
CVS Health monetises through health-insurance premiums and member or sponsor contracts; pharmacy benefit management fees, network economics, formulary management and manufacturer-related drug economics; retail and specialty prescription dispensing; sales of health, wellness and general merchandise; payer reimbursement and value-based-care contracts; pharmaceutical manufacturer commercialisation and co-production arrangements for biosimilars; and retail media. CVS Media Exchange uses CPC sponsored-product auctions, CPM sponsored-brand placements, managed campaign fees, and offsite, video, social, audio and in-store advertising packages.
- Health insurance premiums and plan contracts
- Insurance premium revenue from commercial, Medicare, Medicaid and individual coverage.
- Pharmacy benefit management and prescription fulfilment
- Plan administration, formulary, pharmacy network, specialty and mail-order pharmacy economics.
- Retail pharmacy and consumer wellness sales
- Prescription dispensing and retail margin on health, wellness and general merchandise.
- Care delivery and value-based care
- Payer reimbursement, contracted clinical services and outcome-linked value-based payments.
- Retail media and biosimilar commercialisation
- CPC, CPM and managed advertising fees; manufacturer commercialisation arrangements.
Produkte und Fähigkeiten
Für diese Ansicht liegen keine Produkte mit zugeordneten Quellen vor.
Produkte und Marktkategorien
Zuletzt erfasste Signale
Datumsangaben beziehen sich auf die Quellenveröffentlichung. Ältere Einträge sind historischer Kontext, kein Beleg für ein neues Ereignis.
8-K Financial Filing Analysis for CVS Health (2026-08-17)
financials · Erfasster Impact-Score: 2.5/5
On August 13, 2026, Larry M. Robbins resigned from the Board of Directors of CVS Health Corporation, effective immediately, with no disagreements cited regarding company operations, policies, or practices. Subsequently, on August 17, 2026, CVS Health appointed Teresa Heitsenrether, Executive Vice President and Chief Data & Analytics Officer at JPMorgan Chase & Co., as an independent non-employee director, effective November 18, 2026. Ms. Heitsenrether's compensation will align with the company's standard non-employee director framework, prorated from her start date. This board transition strengthens CVS Health's enterprise data, analytics, and governance expertise without impacting operational guidance.
- Larry M. Robbins resigned from the CVS Health Board of Directors on August 13, 2026, with no disagreements reported.
- Teresa Heitsenrether (EVP and Chief Data & Analytics Officer at JPMorgan Chase) was appointed as an independent director on August 17, 2026, effective November 18, 2026.
Investor Presentation Released: CVS Health Corporation
financials · Erfasster Impact-Score: 4/5
AI parsed presentation narrative: CVS Health delivered strong Q2 2026 results with 7.3% consolidated revenue growth and raised its full-year adjusted EPS guidance. The company is actively driving operational simplification, accelerating AI enablement, and expanding its competitive position as a premier destination for GLP-1 therapies and integrated healthcare services. Strategic pillars: Become best-in-class across the enterprise, Transform the consumer experience.
Unternehmensbeziehungen vertiefen
Fragen zu CVS Health
What is CVS Health?
CVS Health is a US public healthcare corporation operating health insurance, pharmacy benefit management, retail and specialty pharmacy, clinical care and retail media businesses.
Who uses CVS Health?
Its customers include employers, insurers, government programmes, plan sponsors, pharmaceutical manufacturers, providers, advertisers, patients and retail consumers.
How does CVS Health make money?
It earns insurance premiums, PBM and pharmacy-service revenue, prescription and retail sales, payer reimbursements, value-based-care payments, manufacturer revenue and retail-media advertising fees.
Quellen und Datenabdeckung
Dieses Profil nutzt öffentlich zugängliche, offizielle und technisch beobachtbare Informationen. Fehlende Angaben belegen nicht, dass ein Produkt oder eine Beziehung nicht existiert. Die folgende Quellenliste bedeutet nicht, dass jede Aussage im Profil verifiziert wurde.
28 öffentlich erfasste Primärquellen und Zitate im Knowledge-Graphen verknüpft.
Mit CVS Health weiterarbeiten
Explorer bietet zusätzliche Unternehmensdetails, eine Watchlist für bis zu 25 Unternehmen und deinen persönlichen Strategic Intelligence Agenten. Er analysiert deine Märkte täglich – und liefert dir bei Neuigkeiten ein maßgeschneidertes Briefing mit strategischer Einordnung statt Informationsflut.
Kostenlos und ohne zeitliche Begrenzung.